358 related articles for article (PubMed ID: 18720197)
1. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
2. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
Manosroi A; Jantrawut P; Manosroi J
Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
[TBL] [Abstract][Full Text] [Related]
4. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
6. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
[TBL] [Abstract][Full Text] [Related]
9. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
11. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
12. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
14. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
15. Proniosomes as a carrier system for transdermal delivery of tenoxicam.
Ammar HO; Ghorab M; El-Nahhas SA; Higazy IM
Int J Pharm; 2011 Feb; 405(1-2):142-52. PubMed ID: 21129461
[TBL] [Abstract][Full Text] [Related]
16. Proniosomes as drug carriers.
Sankar V; Ruckmani K; Durga S; Jailani S
Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
[TBL] [Abstract][Full Text] [Related]
17. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
18. Preparation of curcuminoid niosomes for enhancement of skin permeation.
Rungphanichkul N; Nimmannit U; Muangsiri W; Rojsitthisak P
Pharmazie; 2011 Aug; 66(8):570-5. PubMed ID: 21901978
[TBL] [Abstract][Full Text] [Related]
19. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
